ASA continues its expansion in Latin America, strengthening the presence of MLS® Laser Therapy among doctors, physiotherapists and specialists in orthopaedics and rehabilitation. With a series of events, training courses and meetings with the main sector professionals, ASA has consolidated its reference role for laser therapy.
In collaboration with its partner Neomedic, ASA organised an event in Barranquilla with over 50 specialist doctors and physiotherapists. During the meeting, Giacomo Granozio, ASA Education Program Manager, illustrated the benefits of MLS® Laser Therapy through scientific studies and clinical cases.A striking case was that of the Clinica La Misericordia, which treated 50 patients with the M8 robotic device, obtaining significant clinical results. In addition, the proposed business model – which integrates MLS®, Hiro TT MLS®, Hiro TT and Qs Magnetotherapy – is creating new opportunities for the orthopaedic sector.
In Panama, ASA collaborated with its partner Casa del Medico to demonstrate the effectiveness of the integration between laser therapy and Tecar therapy. A training course with over 30 specialists, including the president of the Panamanian Association of Physiotherapy and Kinesiology (APAFIK), highlighted how the two technologies are complementary for the effective treatment of musculoskeletal disorders.
Given its success, the course will be repeated in other cities to expand knowledge of the MLS® technology among Panamanian physiotherapists.
The activity in Mexico, with the partner Equipos Interferenciales, included clinical demonstrations, meetings with Universities and specialists. The most important results included:
Thanks to this intense activity, ASA continues to promote MLS® Laser Therapy and Hilterapia® as innovative tools for the treatment of orthopaedic and musculoskeletal disorders: the commitment to training doctors and physiotherapists and the dissemination of successful clinical cases are the basis of the growth of the ASA technologies in Latin American markets.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.